Summary
Psoriasis is a chronic, relapsing dermatosis characterised by scaling, erythema, and less commonly pustulation. Although the clinical spectrum is broad and the nature of the underlying defect responsible for the production of psoriasis uncertain, all currently available effective remedies are capable of inhibiting epidermal mitosis and this remains the most widely accepted concept in the management of psoriasis.
Similar content being viewed by others
References
Bailin, P.L.; Tindall, J.P.; Roenigk, H.H. and Hogan, M.D.: Is methotrexate therapy for psoriasis carcinogenic? Journal of the American Medical Association 232: 359–362 (1975).
Baker, H. and Ryan, T.J.: Generalised pustular psoriasis. British Journal of Dermatology 80: 771–793 (1968).
Beutner, E.H.; Jablonska, S.; Jarzabeck-Chorzelska, M.; Marciejowska, E.; Rzesa, G. and Chorzelski, T.P.: Studies in immunodermatology. VI. I.F. study of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions. International Archives of Allergy and Applied Immunology 48: 301–323 (1975).
Braverman, I.M. and Yen, A.: Microcirculation in psoriatic skin. Journal of Investigative Dermatology 62: 493–502 (1974).
Breza, T.S.; Kechijian, P. and Taylor, J.R.: Mechlorethamine in psoriasis. Further attempts to induce immunologic tolerance. Archives of Dermatology 111: 1438–1439 (1975).
Comaish, J.S. and Juhlin, L.: Site of action of methotrexate in psoriasis. Archives of Dermatology 100: 99–105 (1969).
Christophers, E.; Parzefall, R. and Braun-Falco, O.: Initial events in psoriasis: Quantitative assessment. British Journal of Dermatology 89: 327–334 (1973).
Dahl, M.C.G. and Comaish, J.S.: Long term effects of hydroxyurea in psoriasis. British Medical Journal 4: 585–587 (1972).
Duffill, M.; Wright, N. and Shuster, S.: The cell proliferation kinetics of psoriasis examined by three in vitro techniques. British Journal of Dermatology 94: 355–362 (1976).
Du Vivier, A.; Munro, D.D. and Verbov, J.: Treatment of psoriasis with azathioprine. British Medical Journal 1: 49–51 (1974).
Editorial: Psoriatic arthritis: To lump or to split? British Medical Journal 2: 491-492 (1976).
Fitzpatrick, T.B.; Arndt, K.A.; El Mofty, A.M. and Pathak, M.A.: Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo. Archives of Dermatology 93: 589–599 (1966).
Hadgraft, J.W.: Recent progress in the formulation of vehicles for topical applications. British Journal of Dermatology 87: 386–389 (1972).
Halprin, K.M.; Ohkawara, A. and Levine, V.: Synthesis of glycogen in the psoriatic lesion. Archives of Dermatology 107: 706–711 (1973).
Hodgson, C. and Hell, E.: The action of retinoic acid on psoriatic skin. Clinical and Experimental Dermatology 1: 215–220 (1976).
Jones, E.L.; Epinette, W.W.; Hackney, V.C.; Menendez, L. and Frost, P.: Treatment of psoriasis with oral mycophenolic acid. Journal of Investigative Dermatology 65: 537–542 (1975).
Kaidbey, K.H.; Petrozzi, J.W. and Kligman, A.M.: Topical colchicine therapy for recalcitrant psoriasis. Archives of Dermatology 111: 33–36 (1975).
Levantine, A. and Brostoff, J.: Immunologic responses of patients with psoriasis and the effect of treatment with methotrexate. British Journal of Dermatology 93: 659–666 (1975).
Lomholt, G.: In Psoriasis. Prevalence, spontaneous course and genetics. (G.E.C. Gad, Copenhagen 1963).
Marcusson, J.; Móller, E. and Thyresson, N.: HL-A antigens (17, 27, UPS) in psoriasis with special reference to patients with arthritic lesions. Acta Dermatovenereologica (Stockholm) 55: 297–300 (1975).
Musajo, L.; Rodighiero, G.; Caporale, G.; Dall’acqua, F.; Marciani, S.; Bordin, F.; Baccichetti, F. and Bevilacqua, R.: in Pathak, Harber, Seiji and Kukita (Eds) Sunlight and Man: Normal and Abnormal Photobiologic Responses, p.369–387 (University of Tokyo Press, Tokyo 1974).
Neville, E.A. and Finn, O.A.: Psoriasiform napkin dermatitis — a follow-up study. British Journal of Dermatology 92: 279–285 (1975).
Orfanos, C.E.; Shaumburg-Lever, G.; Mahrle, G. and Lever, W.F.: Alterations of cell surfaces as a pathogenetic factor in psoriasis. Archives of Dermatology 107: 38–46 (1973).
Parrish, J.A.: Photochemotherapy of psoriasis. Archives of Dermatology 112: 35–36 (1976).
Parrish, J.A.; Fitzpatrick, T.B.; Tanenbaum, L. and Pathak, M.A.: Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light. New England Journal of Medicine 291: 1207–1211 (1974).
Pathak, M.A.; Kramer, D.M. and Fitzpatrick, T.B.: Photobiology and photochemistry of furocoumarins (psoralens); in Pathak, Harber, Seiji and Kukita (Eds) Sunlight and Man: Normal and Abnormal Photobiologic Responses, p.335–368 (University of Tokyo Press, Tokyo 1974).
Perry, H.O.; Soderstrom, C.W. and Schulze, R.W.: The Goeckerman treatment of psoriasis. Archives of Dermatology 98: 178–182 (1968).
Pinkus, H. and Mehregan, A.H.: The primary histologie lesion of seborrhoeic dermatitis and psoriasis. Journal of Investigative Dermatology 46: 109–115 (1966).
Seville, R.H.: Simplified dithranol treatment for psoriasis. British Journal of Dermatology 93: 205–208 (1975).
Seville, R.H.: Relapse rate of psoriasis worsened by adding steroids to a dithranol regime. British Journal of Dermatology 95: 643–646 (1976).
Shapiro, H.A.; Trowbridge, J.O.; Lee, J.C. and Maibach, H.I.: Liver Disease in psoriatics — an effect of methotrexate therapy? Archives of Dermatology 110: 547–551 (1974).
Stankler, L.: An experimental investigation on the site of skin damage inducing the Koebner reaction in psoriasis. British Journal of Dermatology 81: 534–535 (1969).
Subcommitteee of the Task Force on Psoriasis, American Academy of Dermatology: Guidelines for the use of azaribine in treatment of psoriasis. Archives of Dermatology 112: 388–390 (1976).
Tagami, H. and Ofuji, S.: Leucotactic properties of soluble substances in psoriatic scale. British Journal of Dermatology 95: 1–8 (1976).
Tanenbaum, L.; Parrish, J.A.; Pathak, M.A.; Anderson, R.R. and Fitzpatrick, T.B.: Tar phototoxicity and phototherapy for psoriasis. Archives of Dermatology 111: 467–470 (1975).
Van Scott, E.J. and Ekel, T.M.: Kinetics gf hyperplasia in psoriasis. Archives of Dermatology 88: 373–381 (1963).
Voorhees, J.J. and Mier, P.D.: The epidermis and cyclic AMP. British Journal of Dermatology 90: 223–227 (1974).
Wagner, G.; Luckasen, J.R. and Goltz, R.W.: Mucous membrane involvement in generalised pustular psoriasis. Archives of Dermatology 112: 1010–1014 (1976).
Weinstein, G.D. and McCullough, J.L.: Cytokinetics and chemotherapy of psoriasis. Journal of Investigative Dermatology 67: 26–30 (1976).
Wolff, K.; Fitzpatrick, T.B.; Parrish, J.A.; Gschnait, F.; Gilchrest, B.; Honigsmann, H.; Pathak, M.A. and Tanenbaum, L.: Photochemotherapy for psoriasis with orally administered methoxsalen. Archives of Dermatology 112: 943–949 (1976).
Yoshikawa, K.; Adachi, K.; Halprin, K.M. and Levine, V.: Is the cyclic AMP in psoriatic epidermis low? British Journal of Dermatology 93: 253–258 (1975).
Zetterberg, G. and Swanbeck, G.: Studies on dithranol and dithranol-like compounds mutagenicity. Acta Dermatovenereologica (Stockholm) 51: 41–44 (1971).
Zackheim, H.S.: Treatment of psoriasis with 6 amino-nicotinamide. Archives of Dermatology 111: 880–882 (1975).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hodge, L., Comaish, J.S. Psoriasis: Current Concepts in Management. Drugs 13, 288–296 (1977). https://doi.org/10.2165/00003495-197713040-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-197713040-00004